STAR Apollo™ Mapping System

FDA 510(k) K240509 · Rhythm AI, Ltd.

Substantially Equivalent

510(k) numberK240509

Submission

Device name
STAR Apollo™ Mapping System
Applicant
Rhythm AI, Ltd.
London, GB
Received
February 22, 2024
Decision date
July 26, 2024
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DQK – Computer, Diagnostic, Programmable
Device class
Class II (moderate risk)
Regulation
21 CFR 870.1425
Specialty
Cardiovascular

Other 510(k)s with product code DQK

510(k)DeviceApplicantDecision
K262005Affera Integrated Mapping SystemDQK · Special Medtronic, Inc.08/21/2026SE
K253692AVVIGO™+ Multi-Modality Guidance SystemDQK · Traditional Boston Scientific08/21/2026SE
K253576CorVista System® with PCWP Add-OnDQK · Traditional Analytics For Life, Inc.07/26/2026SE
K262006EnSite™ X EP SystemDQK · Special Abbott Medical07/15/2026SE
K252978ScioCardio ECG Analysis PlatformDQK · Traditional Synergen Technology Labs, LLC07/09/2026SE
K253463ILR ECG Analyzer (IM007)DQK · Traditional Implicity, Inc.07/02/2026SE
K261119NorthStar Mapping System (MAP01 or MAP01-01)DQK · Special Imricor Medical Systems, Inc.06/30/2026SE
K253088OneStim-DUO Cardiac Stimulator (MP5003-4CO)DQK · Traditional Micropace Pty, Ltd.06/12/2026SE
K261329Intra-Operative Positioning System (IOPS) (MC-1);IOPS Viewpoint Simple Curve Catheter…DQK · Special Centerline Biomedical06/10/2026SE
K252859ZEUS Platform (FG0501US)DQK · Traditional iRhythm Technologies, Inc.05/29/2026SE

More from iRhythm Technologies, Inc.

510(k)DeviceDecision
K253733STAR Apollo™ Mapping SystemDQK · Special 12/19/2025SE

Questions and answers

When was STAR Apollo™ Mapping System cleared by the FDA?

STAR Apollo™ Mapping System (K240509) received a 510(k) decision of Substantially Equivalent on July 26, 2024, 155 days after the submission was received.

What is the product code of K240509?

The FDA product code is DQK – Computer, Diagnostic, Programmable, a Class II (moderate risk) device regulated under 21 CFR 870.1425.